Cardinal Health (NYSE:CAH) Announces Quarterly Earnings Results

Cardinal Health (NYSE:CAH) released its quarterly earnings results on Friday. The company reported $1.88 EPS for the quarter, beating analysts’ consensus estimates of $1.64 by $0.24, Briefing.com reports. Cardinal Health had a negative return on equity of 54.85% and a net margin of 0.37%. The firm had revenue of $52.28 billion for the quarter, compared to analyst estimates of $50.90 billion. During the same quarter in the previous year, the company posted $1.73 EPS. The business’s revenue was down 4.3% on a year-over-year basis. Cardinal Health updated its FY25 guidance to $7.75-7.90 EPS and its FY 2025 guidance to 7.750-7.900 EPS.

Cardinal Health Trading Up 7.0 %

NYSE CAH traded up $7.61 during trading hours on Friday, hitting $116.13. The company’s stock had a trading volume of 3,876,405 shares, compared to its average volume of 2,073,380. The company’s 50-day simple moving average is $111.75 and its two-hundred day simple moving average is $104.19. Cardinal Health has a 52 week low of $91.14 and a 52 week high of $119.13. The company has a market capitalization of $28.10 billion, a PE ratio of 33.56, a price-to-earnings-growth ratio of 1.48 and a beta of 0.60.

Cardinal Health Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, October 15th. Shareholders of record on Tuesday, October 1st were issued a dividend of $0.506 per share. This is an increase from Cardinal Health’s previous quarterly dividend of $0.51. The ex-dividend date of this dividend was Tuesday, October 1st. This represents a $2.02 annualized dividend and a yield of 1.74%. Cardinal Health’s dividend payout ratio is presently 58.38%.

Wall Street Analysts Forecast Growth

Several brokerages recently commented on CAH. Deutsche Bank Aktiengesellschaft upped their target price on Cardinal Health from $115.00 to $119.00 and gave the company a “hold” rating in a report on Friday, August 16th. StockNews.com raised shares of Cardinal Health from a “buy” rating to a “strong-buy” rating in a research note on Saturday, October 26th. Argus upped their price target on shares of Cardinal Health from $115.00 to $125.00 and gave the company a “buy” rating in a research report on Wednesday, September 11th. Evercore ISI lifted their price objective on Cardinal Health from $105.00 to $115.00 and gave the stock an “in-line” rating in a research report on Thursday, August 15th. Finally, UBS Group upped their target price on Cardinal Health from $125.00 to $134.00 and gave the company a “buy” rating in a research report on Tuesday, October 22nd. One equities research analyst has rated the stock with a sell rating, four have given a hold rating, seven have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, Cardinal Health presently has an average rating of “Moderate Buy” and an average price target of $120.18.

Insider Activity at Cardinal Health

In other Cardinal Health news, insider Michelle D. Greene sold 4,000 shares of the stock in a transaction dated Monday, August 19th. The shares were sold at an average price of $108.85, for a total value of $435,400.00. Following the completion of the sale, the insider now owns 19,242 shares in the company, valued at approximately $2,094,491.70. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. In other Cardinal Health news, insider Michelle D. Greene sold 4,000 shares of Cardinal Health stock in a transaction dated Monday, August 19th. The shares were sold at an average price of $108.85, for a total value of $435,400.00. Following the sale, the insider now owns 19,242 shares of the company’s stock, valued at approximately $2,094,491.70. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Jessica L. Mayer sold 16,573 shares of the stock in a transaction on Wednesday, August 21st. The shares were sold at an average price of $109.39, for a total value of $1,812,920.47. Following the transaction, the insider now directly owns 75,971 shares of the company’s stock, valued at approximately $8,310,467.69. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 113,963 shares of company stock valued at $12,379,980. 0.09% of the stock is owned by insiders.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.